Search - tctmd.com

Displaying 21 - 40 of 2268

Sort: Relevancy | Date

News Conference News AHA 2025

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

Caitlin E. Cox

November 09, 2025

News Conference News AHA 2025

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Todd Neale

November 09, 2025

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan

November 08, 2025

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI?

Presenter: Hao-Yu Wang

October 28, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

Presentation TCT 2025

Reperfuse First and Avoid Bleeding

Presenter: Vijay Kunadian

October 27, 2025

Presentation TCT 2025

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

Presenter: Davide Cao

October 27, 2025

Presentation TCT 2025

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

Presenter: Francesca Maria Di Muro

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 1822: Treating a Severely Calcified Left Main With Nodular Calcium: Lithotripsy and DCB-Only Strategy in a High Bleeding Risk Case

Presenter: Edgar Stroppa Lamas

October 26, 2025

Advertisement

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI?

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Reperfuse First and Avoid Bleeding

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

TCT 1822: Treating a Severely Calcified Left Main With Nodular Calcium: Lithotripsy and DCB-Only Strategy in a High Bleeding Risk Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content